MyFinsight
Home
Blog
About
Contact
Download
Download image
Cash and cash
equivalents, including...
$64,788K
Inventories
$20,424K
Trade receivables,
net of allowances of...
$9,741K
Prepaid expenses and
other assets
$1,312K
Assets held for sale
$541K
Total current assets
$96,806K
Intangible assets, net
$5,660K
Right-of-use assets
$2,192K
Leasehold improvements
and equipment, net
$1,323K
Other long-term
assets
$425K
Total assets
$106,406K
Total liabilities and
stockholders' equity
$106,406K
Total stockholders'
equity
$76,533K
Total liabilities
$29,873K
Accumulated deficit
-$164,528K
Cumulative translation
adjustments
-$9K
Additional paid-in capital
$240,991K
Total current
liabilities
$19,919K
Deferred consideration
liability
$5,465K
Deferred revenue
$2,674K
Operating lease
obligations, less current...
$1,815K
Common stock, 0.001 par
value authorized...
$79K
Accounts payable
$10,796K
Accrued expenses
$7,722K
Current maturities of
operating lease...
$1,002K
Customer deposits
$399K
Back
Back
Balance Sheet
source: myfinsight.com
Niagen Bioscience, Inc. (NAGE)
Niagen Bioscience, Inc. (NAGE)